Female HD patients consistently experience poorer HRQoL than males across multiple SF-36 and select KDQOL domains. These findings highlight the need for sex-sensitive interventions, such as tailored pain management and psychosocial support, to improve quality of life in females receiving HD.
Onalbekov et al. (Wed,) studied this question.